An interventional study of Placebo and Vitamin K2 in Diabete Type 2, sponsored by Dasman Diabetes Institute. Recruiting at 1 site in Kuwait. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2023-07-28.
Sponsored by Dasman Diabetes Institute · Not applicable, Interventional, and Treatment
The aim of the current study is to determine the effects of vitamin K2 supplementation on muscle size and function in adults with muscle weakness and type 2 diabetes.
10,371 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,406 are open to participants now.
This study's planned enrollment of 150 is above the median of 80 across 8,350 interventional studies indexed under Diabetes Mellitus, Type 2.
Browse Diabetes Mellitus, Type 2 studies →Dasman Diabetes Institute is the lead sponsor of 31 studies on the registry; 14 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
micro-crystalline cellulose placebo (one 380 mg tablet per day)
Dietary Supplement: Placebo
micro-crystalline cellulose (one 380 mg tablet per day) where vitamin K2 (K2VITAL® 0.2% DELTA powder) is mixed into the formulation to a final vitamin K2 concentration of 240 μg/tablet
Dietary Supplement: Vitamin K2
Placebo
Vitamin K2
Grip Strength
Change in Grip Strength
Time frame: Baseline to one year
SPPB
Change in Short Performance Physical Battery Test
Time frame: Baseline to one year
HbA1c
Change in glycated haemoglobin
Time frame: Baseline to one year
Blood Pressure
Change in blood pressure
Time frame: Baseline to one year
Body Mass
Change in body mass
Time frame: Baseline to one year
Lean Mass
Change in lean mass
Time frame: Baseline to one year
Body Fat
Change in body fat
Time frame: Baseline to one year
BMC
Change in bone mineral content
Time frame: Baseline to one year
BMD
Change in bone mineral density
Time frame: Baseline to one year
Vitamin K status
Change in vitamin K status
Time frame: Baseline to one year
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Vitamin K 2
Dasman Diabetes Institute